Premium
S4‐01‐04: Phase IIa clinical trial on Alzheimer's disease with NP12, a GSK3 inhibitor
Alzheimer's And DementiaPeer ReviewedTeodoro del Ser2010Journals

This content is not available in your region!

Continue researching from Zendy home

Having issues? Contact support